DocGo Q4 Revenue at $74.9M, Exceeds Expectations
Reports Q4 revenue $74.9M, consensus $70.4M. Lee Bienstock, Chief Executive Officer of DocGo, commented "While 2025 was a year of transition and focus on our core business lines, the robust growth in our 'healthcare at any address' business - which includes care in the home, remote patient monitoring, mobile phlebotomy and virtual care services - supports our belief that DocGo's offering is well positioned to meet the needs of the evolving healthcare landscape." Bienstock continued "We are increasing guidance based on the record volumes we've seen thus far in 2026, and the anticipated full-year impact of our cost efficiency initiatives. We believe that our plan and resources are sufficient to enable the Company to achieve profitability in the second half of 2026."
